Farmas USA

OCAT ayer +6% , hoy haciendose un +10 ... pues nada me olvido de comprarla el Lunes , se va. Tiene pinta de querer mas , buena suerte.

me quedo con las THLD. la prox semana con los datos de Myeloma a ver que hace. De momento creo que ya ha roto la MM50, veremos si aguanta.
THLD

GAS

Pues ahí están los 3,75 pero nos los creemos del todo? Como dices, siendo viernes, mejor dejarlo para la semana que viene.

DVAX

De momento se está portando. Dilución de 50 millones y por ahora +1,5%. Que dure!

ANTH

Me la he estado estudiando un poco:

On November 18, 2014, Anthera Pharmaceuticals, Inc. ("the Company") received a letter from The Nasdaq Stock Market informing the Company that its most recent Form 10-Q for the period ended September 30, 2014 reported stockholders' equity fell below the minimum of $10,000,000 for continued inclusion under Listing Rule 5450(b)(1)(A). The letter stated that the Company may submit a plan to regain compliance to Nasdaq within 45 days of receipt of the letter. The Company intends to do so. If the plan is accepted, Nasdaq can grant an extension of up to 180 days for the Company to regain compliance.

Último informe trimestral

As of the date of this report, the Company anticipates its existing cash, cash equivalents and access to additional capital through an equity purchase agreement and equity offering are sufficient to fund its near term liquidity needs for at least the next 12 months.
As of June 30, 2014, we had cash and cash equivalents of approximately $20.9 million.
As of June 30, 2014, $75 million remained available for future issuance under this shelf registration statement.

Based on this evaluation, our chief executive officer and principal accounting officer concluded that our disclosure controls and procedures were not effective as of June 30, 2014 at the reasonable assurance level due to a material weakness that we identified as of December 31, 2013 that has not been fully remediated. The material weakness we identified relates to the lack of a process to timely and appropriately account for warrants that provided the holders with anti-dilution price protection. The material weakness resulted in restatement of our consolidated financial statements for the years ended December 31, 2010, 2011 and 2012, respectively, and each of the quarterly periods from March 31, 2012 through September 30, 2012. Notwithstanding the existence of the material weakness, management has concluded that the consolidated financial statements included in this report present fairly, in all material respects, our consolidated financial position, results of operations and cash flows for the periods presented in conformity with U.S. GAAP. We began the implementation of the remediation activities in the second quarter of 2014. As of June 30, 2014, we have not yet been able to remediate this material weakness but intend to fully remediate the weakness by the end of the current fiscal year.

Esto unido a que han sacado una enmienda al informe trimestral que no sé para que sirve sino para incluir el siguiente punto para cubrir a los directivos me da yuyu:

Section 145 of the Delaware General Corporation Law (the “DGCL”) authorizes a corporation to indemnify its directors and officers against liabilities arising out of actions, suits and proceedings to which they are made or threatened to be made a party by reason of the fact that they have served or are currently serving as a director or officer to a corporation. The indemnity may cover expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by the director or officer in connection with any such action, suit or proceeding

Bien por THLD. Sin volumen pero sube y ya es decir mucho eso.
La proxima semana resultados de Myeloma.

Fuera de THLD en 3,20. +7,5% en semana y algo. Y ya veremos la proxima semana lo que hace esta pajara ... 

Anda que hacia tiempo que no tradeaba yo , sienta bien al cuerpo ! :)

¡Bien framus! Profits a la buchaca, ni a los resultados de Myeloma has podido esperar, jajaja.
Esta semana las dos de cal
THLD +11.03%
NVAX + 2.34%
IBB + 1.62%

Que dure la fiesta:)

Con esos profits reduzco el "bujerillo" de SNTA al 50%, no me he podido resistir. 

Si para fin de año no recupero SNTA las amputo y compenso minus y ya esta.